Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| BVF Partners L.P. | Institution | 6.385.310 | 8,26% | US$ 25,35M | 2026-03-31 |
| BlackRock, Inc. | Institution | 4.382.245 | 5,67% | US$ 17,40M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 3.855.876 | 4,99% | US$ 15,31M | 2026-03-31 |
| Defilade Capital Management, L.P. | Institution | 3.564.127 | 4,61% | US$ 14,15M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 3.293.134 | 4,26% | US$ 13,07M | 2026-03-31 |
| Armistice Capital Master Fund Ltd. | Institution | 3.137.553 | 4,06% | US$ 12,46M | 2024-12-31 |
| Armistice Capital LLC | Institution | 3.137.553 | 4,06% | US$ 12,46M | 2024-12-31 |
| Ensign Peak Advisors, Inc. | Institution | 2.464.919 | 3,19% | US$ 9,79M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 2.092.550 | 2,71% | US$ 8,31M | 2026-03-31 |
| Zimmer Partners, LP | Institution | 1.875.000 | 2,43% | US$ 7,44M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1.791.783 | 2,32% | US$ 7,11M | 2026-03-31 |
| Sphera Funds Management Ltd | Institution | 1.772.131 | 2,29% | US$ 7,04M | 2026-03-31 |
| Catalio Capital Management, LP | Institution | 1.639.816 | 2,12% | US$ 6,51M | 2026-03-31 |
| CHI Advisors LLC | Institution | 1.419.912 | 1,84% | US$ 5,64M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1.154.671 | 1,49% | US$ 4,58M | 2026-03-31 |
| AWM Investment Company Inc | Institution | 1.100.000 | 1,42% | US$ 4,37M | 2026-03-31 |
| Jefferies Financial Group Inc. | Institution | 1.094.456 | 1,42% | US$ 4,34M | 2026-03-31 |
| Kingdon Capital Management, L.L.C. | Institution | 1.039.275 | 1,34% | US$ 4,13M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 974.421 | 1,26% | US$ 3,87M | 2026-03-31 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 878.080 | 1,14% | US$ 3,49M | 2024-12-31 |
| Bank of America Corporation | Institution | 869.544 | 1,12% | US$ 3,45M | 2026-03-31 |
| Sanofi | Institution | 814.980 | 1,05% | US$ 3,24M | 2026-03-31 |
| CM Management, LLC | Institution | 650.000 | 0,84% | US$ 2,58M | 2026-03-31 |
| 22NW, LP | Institution | 636.364 | 0,82% | US$ 2,53M | 2026-03-31 |
| SG Americas Securities, LLC | Institution | 635.845 | 0,82% | US$ 2,52M | 2026-03-31 |
| UBS Asset Management AG | Institution | 547.447 | 0,71% | US$ 2,17M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 543.842 | 0,70% | US$ 2,16M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 503.764 | 0,65% | US$ 2,00M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 429.889 | 0,56% | US$ 1,71M | 2026-03-31 |
| Biotechnology Value Trading Fund OS LP | Institution | 307.988 | 0,40% | US$ 1,22M | 2026-03-31 |
| Medical Strategy GmbH | Institution | 294.485 | 0,38% | US$ 1,17M | 2025-06-30 |
| Frazier Life Sciences Public Overage Fund, L.P. | Institution | 258.998 | 0,34% | US$ 1,03M | 2024-12-31 |
| Goldman Sachs Asset Management, L.P. | Institution | 245.085 | 0,32% | US$ 972,99k | 2026-03-31 |
| Brevan Howard Capital Management LP | Institution | 228.557 | 0,30% | US$ 907,37k | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 194.022 | 0,25% | US$ 770,27k | 2026-03-31 |
| AQR Capital Management, LLC | Institution | 164.619 | 0,21% | US$ 653,54k | 2026-03-31 |
| BNY Asset Management | Institution | 144.148 | 0,19% | US$ 572,27k | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
